RILONACEPT

Serial Number 77252679
606

Registration Progress

Application Filed
Aug 10, 2007
Under Examination
May 6, 2008
Approved for Publication
Jan 23, 2008
Published for Opposition
Feb 12, 2008
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: RILONACEPT
Previous Owner: Regeneron Pharmaceuticals, Inc.
Classes: 005

Trademark Image

RILONACEPT

Basic Information

Serial Number
77252679
Filing Date
August 10, 2007
Published for Opposition
February 12, 2008
Abandonment Date
December 8, 2008
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Dec 8, 2008
Classes
005

Rights Holder

Regeneron Pharmaceuticals, Inc.

03
Address
777 Old Saw Mill River Road
Tarrytown, NY 10591

Ownership History

Regeneron Pharmaceuticals, Inc.

Original Applicant
03
Tarrytown, NY

Regeneron Pharmaceuticals, Inc.

Owner at Publication
03
Tarrytown, NY

Legal Representation

Attorney
Terrence J. McAllister

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

11 events
Date Code Type Description Documents
Dec 8, 2008 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Loading...
Dec 8, 2008 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
May 6, 2008 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT Loading...
Feb 12, 2008 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 23, 2008 NPUB O NOTICE OF PUBLICATION Loading...
Jan 9, 2008 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Jan 9, 2008 ALIE A ASSIGNED TO LIE Loading...
Jan 8, 2008 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 23, 2007 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Nov 16, 2007 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 15, 2007 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations and substances for the treatment of immunological diseases and disorders, heart and circulatory diseases, hypertension, cardiovascular diseases, urological diseases, gastrointestinal disorders, metabolic diseases, chronic peripheral arterial occlusive diseases, inflammatory diseases and disorders
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005